QCLSNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Q/C TECHNOLOGIES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.50−0.04 (-7.10%)
Close on Oct 19, 2026
- Market cap
- $4.12M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.8900 (−88.61%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $4.12M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.26
- Dividend yield
- –
- Free cash flow yield
- -262.64%
Fundamentals
- Net income
- -$16.57M
- EPS, diluted
- -$8.66
- Free cash flow
- -$10.82M
- Book value per share
- $1.95
- Diluted shares
- 8M
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$14.15M
Net income
-$16.57M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months